PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-06-09 (1)

Date Title Company
09-Jun-2023 FDA Accepts Biologics License Applications for exagamglogene autotemcel (exa-cel) for Severe Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia Businesswire